Type 2 diabetes mellitus and characteristics of breast cancer in China

Asian Pacific Journal of Cancer Prevention

Volumn 11, Issue 4, 2010, Pages 933-937

  Liao, Shichong ^a   Li, Jinxin ^a   Wang, Lijun ^a   Zhang, Yimin ^a   Wang, Changhua ^b   Hu, Mingbo ^b   Ma, Biao ^c   Wang, Geng ^d   Sun, Shengrong ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

^c Hubei Provincial Tumor Hospital   (China)

^d Taihe Hospital   (China)

Author keywords

Breast cancer; Characteristics; Diabetes mellitus; Stage

Indexed keywords

EID: 78650689080     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Barb D, Williams CJ, Neuwirth AK, et al (2007). Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence. Am J Clin Nutr, 86, 858-66.
2. Bartella V, Cascio S, Fiorio E, et al (2008). Insulin-dependent leptin expression in breast cancer cells. Cancer Res, 68, 4919-27.
3. Carol DeSantis, Melissa M, Rebecca Siegel, et al (2010). Breast cancer facts and figures 2009-2010. American Cancer Society: Atlanta.
4. Call R, Grimsley M, Cadwallader L, et al (2009). Insulin-carcinogen or mitogen? Preclinical and clinical evidence from prostate, breast, pancreatic, and colorectal cancer research. Postgrad Med, 122, 158-65
5. Centers for Disease Control and Prevention (2005). National diabetes surveillance system: prevalence of diabetes. Version current 6 October.
6. Cseh A, Szebeni B, Szalay B, et al (2009). Akt enzyme: new therapeutic target in cancer and diabetes? Orv Hetil, 150, 373-8.
7. Cust AE, Stocks T, Lukanova A, et al (2009). The influence of overweight and insulin resistance on breast cancer risk and tumour stage at diagnosis: a prospective study. Breast Cancer Res Treat, 113, 567-76.
8. Dankner R, Chetrit A, Segal P. (2007). Glucose tolerance status and 20 year cancer incidence. Isr Med Assoc J, 9, 592-6.
9. Garmendia ML, Pereira A, Alvarado ME, et al.(2007). Relation between insulin resistance and breast cancer among Chilean women. Ann Epidemiol, 17, 403-9.
10. Goodwin PJ, Ennis M, Pritchard Kl, et al (2002). Insulin-like growth factor binding proteins 1 and 3 and breast cancer outcomes. Breast Cancer Res Treat, 74, 65-76.
11. Guastamacchia E, Resta F, Mangia A, et al (2003). Breast cancer:biological characteristics in postmenopausal type 2 diabeticwomen. Identification of therapeutic targets. Curr Drug Targets Immune Endocr Metabol Disord, 3, 205-9.
12. Kaklamani VG, Sadim M, Hsi A, et al (2008). Variants of the adiponectin and adiponectin receptor 1 genes and breast cancer risk. Cancer Res, 68, 3178-84.
13. Karaduman M, Bilici A, Ozet A, et al (2007). Tissue levels of adiponectin in breast cancer patients. Med Oncol, 24, 361-6.
14. Khan M, Mori M, Fujino Y, et al (2006). Site-specific cancer risk due to diabetes mellitus history:evidence from the Japan Collaborative Cohort (JACC) Study. Asian Pac J Cancer Prev, 7, 253-9.
15. Krone CA, Ely JT (2005). Controlling hyperglycemia as an adjunct to cancer therapy. Integr Cancer Ther, 4, 25-31.
16. Lipscombe LL, Goodwin PJ, Zinman B, et al (2006). Diabetes mellitus and breast cancer: a retrospective population-based cohort study. Breast Cancer Res Treat, 98, 349-56.
17. Novosyadlyy R, Lann DE, Vijayakumar A, et al (2010). Insulin-mediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetes. Cancer Res, 70, 741-51.
18. Papa V, Pezzino V, Costantino A, et al (1990). Elevated insulin receptor content in human breast cancer. J Clin Invest, 86, 1503-10.
19. Rollison DE, Giuliano AR, Sellers TA, et al (2008). Population based case-control study of diabetes and breast cancer risk in hispanic and non-hispanic white women living in US southwestern states. Am J Epidemiol, 167, 447-56.
20. Stoll BA (2002). Upper abdominal obesity, insulin resistance and breast cancer risk. Int J Obes Relat Metab Disord, 26,747-53.
21. Susanna C, Larsson1, Christos S, et al (2007). Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer, 121, 856-62.
22. Williams GP (2010). The role of oestrogen in the pathogenesis of obesity, type 2 diabetes, breast cancer and prostate disease. Eur J Cancer Prev, 19, 256-71.
23. Wolf I, Sadetzki S, Glucka I, et al (2006). Association between diabetes mellitus and adverse characteristics of breast cancer at presentation. Eur J Cancer, 42, 1077-82.
24. World Health Organization, Definition (1999). Diagnosis and classification of diabetes mellitus and its complications. World Health Organization:Geneva.
25. Wu AH, Yu MC, Tseng CC, et al (2007). Diabetes and risk of breast cancer in Asian-American women. Carcinogenesis, 28,1561-6.
26. Yancik R, Wesley MN, Ries LA, et al (2001). Effect of age and co-morbidity ipostmenopausal breast cancer patient s aged 55 years and older. JAMA, 285, 885-92.